BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21518267)

  • 1. Wnt5a: its signalling, functions and implication in diseases.
    Kikuchi A; Yamamoto H; Sato A; Matsumoto S
    Acta Physiol (Oxf); 2012 Jan; 204(1):17-33. PubMed ID: 21518267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt5a regulates distinct signalling pathways by binding to Frizzled2.
    Sato A; Yamamoto H; Sakane H; Koyama H; Kikuchi A
    EMBO J; 2010 Jan; 29(1):41-54. PubMed ID: 19910923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of focal adhesion dynamics by Wnt5a signaling.
    Matsumoto S; Kikuchi A
    Methods Mol Biol; 2012; 839():215-27. PubMed ID: 22218904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha.
    Yang DH; Yoon JY; Lee SH; Bryja V; Andersson ER; Arenas E; Kwon YG; Choi KY
    Circ Res; 2009 Feb; 104(3):372-9. PubMed ID: 19096028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration.
    Yang J; Cusimano A; Monga JK; Preziosi ME; Pullara F; Calero G; Lang R; Yamaguchi TP; Nejak-Bowen KN; Monga SP
    Am J Pathol; 2015 Aug; 185(8):2194-205. PubMed ID: 26100214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt5a signaling controls cytokinesis by correctly positioning ESCRT-III at the midbody.
    Fumoto K; Kikuchi K; Gon H; Kikuchi A
    J Cell Sci; 2012 Oct; 125(Pt 20):4822-32. PubMed ID: 22825874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt5a attenuates Wnt/β-catenin signalling in human dermal papilla cells.
    Kwack MH; Kim MK; Kim JC; Sung YK
    Exp Dermatol; 2013 Mar; 22(3):229-31. PubMed ID: 23489428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging differentially modulates the Wnt pro-survival signalling pathways in vascular smooth muscle cells.
    Brown BA; Connolly GM; Mill CEJ; Williams H; Angelini GD; Johnson JL; George SJ
    Aging Cell; 2019 Feb; 18(1):e12844. PubMed ID: 30548452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis.
    Hanaki H; Yamamoto H; Sakane H; Matsumoto S; Ohdan H; Sato A; Kikuchi A
    Mol Cancer Ther; 2012 Feb; 11(2):298-307. PubMed ID: 22101459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt11 in 2011 - the regulation and function of a non-canonical Wnt.
    Uysal-Onganer P; Kypta RM
    Acta Physiol (Oxf); 2012 Jan; 204(1):52-64. PubMed ID: 21447091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.
    Kim J; Kim J; Kim DW; Ha Y; Ihm MH; Kim H; Song K; Lee I
    J Immunol; 2010 Jul; 185(2):1274-82. PubMed ID: 20554957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice.
    Kiyohashi K; Kakinuma S; Kamiya A; Sakamoto N; Nitta S; Yamanaka H; Yoshino K; Fujiki J; Murakawa M; Kusano-Kitazume A; Shimizu H; Okamoto R; Azuma S; Nakagawa M; Asahina Y; Tanimizu N; Kikuchi A; Nakauchi H; Watanabe M
    Hepatology; 2013 Jun; 57(6):2502-13. PubMed ID: 23386589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endocytosis blocks Wnt signalling to beta-catenin by promoting dishevelled degradation.
    Bryja V; Cajánek L; Grahn A; Schulte G
    Acta Physiol (Oxf); 2007 May; 190(1):55-61. PubMed ID: 17428233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
    Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-Catenin and Wnt5a/Ca Pathways Regulate Proliferation and Apoptosis of Keratinocytes in Psoriasis Lesions.
    Zhang Y; Tu C; Zhang D; Zheng Y; Peng Z; Feng Y; Xiao S; Li Z
    Cell Physiol Biochem; 2015; 36(5):1890-902. PubMed ID: 26202350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.
    Yamamoto H; Oue N; Sato A; Hasegawa Y; Yamamoto H; Matsubara A; Yasui W; Kikuchi A
    Oncogene; 2010 Apr; 29(14):2036-46. PubMed ID: 20101234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
    Pourreyron C; Reilly L; Proby C; Panteleyev A; Fleming C; McLean K; South AP; Foerster J
    PLoS One; 2012; 7(2):e31827. PubMed ID: 22384081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissection of sets of genes that control the character of wnt5a-deficient mouse calvarial cells.
    Guo J; Jin J; Cooper LF
    Bone; 2008 Nov; 43(5):961-71. PubMed ID: 18656562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis.
    Deutscher E; Hung-Chang Yao H
    Dev Biol; 2007 Jul; 307(2):227-36. PubMed ID: 17532316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.